Shahnaz Rahim

575 total citations
19 papers, 456 citations indexed

About

Shahnaz Rahim is a scholar working on Organic Chemistry, Oncology and Epidemiology. According to data from OpenAlex, Shahnaz Rahim has authored 19 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Organic Chemistry, 8 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Shahnaz Rahim's work include Metal complexes synthesis and properties (7 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers) and Crystal structures of chemical compounds (4 papers). Shahnaz Rahim is often cited by papers focused on Metal complexes synthesis and properties (7 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers) and Crystal structures of chemical compounds (4 papers). Shahnaz Rahim collaborates with scholars based in United Kingdom, Pakistan and Saudi Arabia. Shahnaz Rahim's co-authors include Richard Walker, A. S. JONES, Erik De Clercq, G. VERHELST, Ginger E. Dutschman, Ying‐Chih Cheng, George W. Hardy, Paul L. Coe, Niaz Muhammad and G. Darby and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Journal of Medicinal Chemistry.

In The Last Decade

Shahnaz Rahim

18 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shahnaz Rahim United Kingdom 11 182 172 171 113 91 19 456
Merrick R. Almond United States 13 222 1.2× 301 1.8× 243 1.4× 82 0.7× 176 1.9× 24 747
Joan A. Harrington United States 14 130 0.7× 188 1.1× 76 0.4× 210 1.9× 90 1.0× 18 543
Geraldine Bebernitz United States 15 175 1.0× 228 1.3× 117 0.7× 139 1.2× 91 1.0× 25 604
Jesus M. Ontoria Italy 18 60 0.3× 410 2.4× 287 1.7× 304 2.7× 86 0.9× 26 796
Chantal Grand‐Maître Canada 15 104 0.6× 308 1.8× 360 2.1× 37 0.3× 151 1.7× 23 663
Gulrez Fazal Canada 13 275 1.5× 207 1.2× 256 1.5× 46 0.4× 267 2.9× 16 810
Tai‐Shun Lin United States 14 236 1.3× 393 2.3× 248 1.5× 152 1.3× 503 5.5× 34 932
G. Arnett United States 11 145 0.8× 127 0.7× 96 0.6× 69 0.6× 91 1.0× 19 337
Davide Carta Italy 14 55 0.3× 200 1.2× 195 1.1× 93 0.8× 55 0.6× 35 535
Matthieu Desroses Sweden 15 82 0.5× 423 2.5× 222 1.3× 67 0.6× 185 2.0× 24 692

Countries citing papers authored by Shahnaz Rahim

Since Specialization
Citations

This map shows the geographic impact of Shahnaz Rahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shahnaz Rahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shahnaz Rahim more than expected).

Fields of papers citing papers by Shahnaz Rahim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shahnaz Rahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shahnaz Rahim. The network helps show where Shahnaz Rahim may publish in the future.

Co-authorship network of co-authors of Shahnaz Rahim

This figure shows the co-authorship network connecting the top 25 collaborators of Shahnaz Rahim. A scholar is included among the top collaborators of Shahnaz Rahim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shahnaz Rahim. Shahnaz Rahim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Rahim, Shahnaz, Abdul Sadiq, Aneela Javed, et al.. (2024). In vitro anticancer, antioxidant, antimicrobial, antileishmanial, enzymes inhibition and in vivo anti-inflammatory activities of organotin(IV) derivatives of 4-bromophenoxyacetic acid. Journal of Molecular Structure. 1313. 138703–138703. 10 indexed citations
3.
Rahim, Shahnaz, Abdul Sadiq, Aneela Javed, et al.. (2024). Synthesis, characterization, enzyme inhibition, antioxidant, anticancer and antimicrobial potential of organotin(IV) derivatives of 4-fluorophenoxyacetic acid. Arabian Journal of Chemistry. 17(4). 105698–105698. 6 indexed citations
4.
Rahim, Shahnaz, et al.. (2023). Reactivity of a series of triaryl borates, B(OArx)3, in hydroboration catalysis. Dalton Transactions. 52(44). 16118–16122. 2 indexed citations
5.
Muhammad, Niaz, Awal Noor, Muhammad Sirajuddin, et al.. (2023). Designing and Exploration of the Biological Potentials of Novel Centrosymmetric Heteroleptic Copper(II) Carboxylates. Pharmaceuticals. 16(10). 1462–1462. 4 indexed citations
6.
Rahim, Shahnaz, Katherine B. Holt, Jeremy K. Cockcroft, et al.. (2023). Synthesis, characterization, X‐ray structure, DNA binding, antioxidant and docking study of new organotin(IV) complexes. Applied Organometallic Chemistry. 37(8). 14 indexed citations
7.
8.
Naz, Saba, Sammer Yousuf, Shahnaz Rahim, et al.. (2022). Homo- and heteroleptic 3-methylbenzoates of zinc(II) ion based on N-donor heterocycles; structure, DNA binding and pharmacological evaluation. Journal of Molecular Liquids. 368. 120792–120792. 8 indexed citations
9.
Muhammad, Niaz, Muhammad Ikram, Abdul Wadood, et al.. (2017). Synthesis, crystal structure, DNA binding and molecular docking studies of zinc(II) carboxylates. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 190. 368–377. 22 indexed citations
10.
Westwood, Nigel, et al.. (1998). Efficient Syntheses of ( E )-5-(2-Bromovinyl)-2′-deoxy-4-thiouridine; A Nucleoside Analogue with Potent Biological Activity. Nucleosides and Nucleotides. 17(1-3). 29–38. 6 indexed citations
11.
Rahim, Shahnaz, Naimisha Trivedi, George W. Hardy, et al.. (1996). Synthesis and Anti-Herpes Virus Activity of 2‘-Deoxy-4‘-thiopyrimidine Nucleosides. Journal of Medicinal Chemistry. 39(3). 789–795. 75 indexed citations
12.
Fyfe, James A., Shahnaz Rahim, Susan M. Daluge, et al.. (1993). Varicella-Zoster virus thymidine kinase. Biochemical Pharmacology. 46(12). 2209–2218. 12 indexed citations
13.
Purifoy, D. J. M., Lilia M. Beauchamp, P de Miranda, et al.. (1993). Review of research leading to new anti-herpesvirus agents in clinical development: Valaciclovir hydrochloride (256u, the L-valyl ester of acyclovir) and 882c, a specific agent for varicella zoster virus. Journal of Medical Virology. 41(S1). 139–145. 38 indexed citations
14.
Rahim, Shahnaz, J. W. T. Selway, G. Darby, et al.. (1992). 5-Alkynyl Pyrimidine Nucleosides as Potent Selective Inhibitors of Varicella-Zoster Virus. Antiviral chemistry & chemotherapy. 3(5). 293–297. 25 indexed citations
15.
Koole, Léo H., Janez Plavec, Hongying Liu, et al.. (1992). Conformation of two 4'-thio-2'-deoxynucleoside analogs studied by 5000-MHz proton NMR spectroscopy and x-ray crystallography.. Journal of the American Chemical Society. 114(25). 9936–9943. 48 indexed citations
16.
17.
Rahim, Shahnaz, Mary Duggan, Richard Walker, et al.. (1982). Synthesis and biological properties of 2′-deoxy-5-vinyluridine and 2′-deoxy-5-vinylcytidine. Nucleic Acids Research. 10(17). 5285–5294. 28 indexed citations
18.
Cheng, Ying‐Chih, Ginger E. Dutschman, Erik De Clercq, et al.. (1981). Differential Affinities of 5-(2-Halogenovinyl)-2'-Deoxyuridines for Deoxythymidine Kinases of Various Origins. Molecular Pharmacology. 20(1). 230–233. 115 indexed citations
19.
JONES, A. S., Shahnaz Rahim, Richard Walker, & Erik De Clercq. (1981). Synthesis and antiviral properties of (Z)-5-(2-bromovinyl)-2'-deoxyuridine. Journal of Medicinal Chemistry. 24(6). 759–760. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Merrick R. Almond Breakdown of academic impact, for papers by Joan A. Harrington Breakdown of academic impact, for papers by Geraldine Bebernitz Breakdown of academic impact, for papers by Jesus M. Ontoria Breakdown of academic impact, for papers by Chantal Grand‐Maître Breakdown of academic impact, for papers by Gulrez Fazal Breakdown of academic impact, for papers by Tai‐Shun Lin Breakdown of academic impact, for papers by G. Arnett Breakdown of academic impact, for papers by Davide Carta Breakdown of academic impact, for papers by Matthieu Desroses
Rankless by CCL
2026